Archive: 07/02/2012

Justifying insurance coverage for orphan drugs

How can insurers justify spending hundreds of thousands of dollars per patient per year on "orphan drugs" – extremely expensive medications for rare conditions that are mostly chronic and life-threatening -- when this ...

Economic factors impact orthopaedic trauma volume

Previous studies have found that human behavior during a recession is remarkably different than that during a bullish economy. For example, people tend to spend more time focused on working and less time engaging in leisure ...

page 1 from 8